学科与关键词
关键词
SGLT2 inhibitorsfinerenonetype 2 diabeteschronic kidney diseaserenal failureheart failure
- Does Combination Therapy With SGLT2 Inhibitors and Renin-Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?Zhao, Li-Min; Zhang, Miao; Zhan, Ze-Lin; Qiu, Mei*Frontiers in Cardiovascular Medicine, 2021, 8: 679124.被引 5
- Do four SGLT2 inhibitors lead to different cardiorenal benefits in type 2 diabetes, in chronic heart failure, and in chronic kidney disease?Qiu, Mei*; Ding, Liang-Liang; Zhan, Ze-Lin; Zhou, Hai-RongEuropean Journal of Internal Medicine, 2021, 87: 98-99.被引 3
- Meta-analysis of the effects of four factors on the efficacy of SGLT2 inhibitors in patients with HFrEFQiu, Mei*; Ding, Liang-Liang; Zhan, Ze-Lin; Zhou, Hai-RongESC Heart Failure, 2021, 8(2): 1722-1724.被引 2
